» Articles » PMID: 24166207

New Developments in the Evolution and Application of the WHO/IPCS Framework on Mode of Action/species Concordance Analysis

Overview
Journal J Appl Toxicol
Specialty Toxicology
Date 2013 Oct 30
PMID 24166207
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

The World Health Organization/International Programme on Chemical Safety mode of action/human relevance framework has been updated to reflect the experience acquired in its application and extend its utility to emerging areas in toxicity testing and non-testing methods. The underlying principles have not changed, but the framework's scope has been extended to enable integration of information at different levels of biological organization and reflect evolving experience in a much broader range of potential applications. Mode of action/species concordance analysis can also inform hypothesis-based data generation and research priorities in support of risk assessment. The modified framework is incorporated within a roadmap, with feedback loops encouraging continuous refinement of fit-for-purpose testing strategies and risk assessment. Important in this construct is consideration of dose-response relationships and species concordance analysis in weight of evidence. The modified Bradford Hill considerations have been updated and additionally articulated to reflect increasing experience in application for cases where the toxicological outcome of chemical exposure is known. The modified framework can be used as originally intended, where the toxicological effects of chemical exposure are known, or in hypothesizing effects resulting from chemical exposure, using information on putative key events in established modes of action from appropriate in vitro or in silico systems and other lines of evidence. This modified mode of action framework and accompanying roadmap and case examples are expected to contribute to improving transparency in explicitly addressing weight of evidence considerations in mode of action/species concordance analysis based on both conventional data sources and evolving methods.

Citing Articles

Risks to human and animal health from the presence of bromide in food and feed.

Bennekou S, Allende A, Bearth A, Casacuberta J, Castle L, Coja T EFSA J. 2025; 23(1):e9121.

PMID: 39877303 PMC: 11773346. DOI: 10.2903/j.efsa.2025.9121.


Adverse Outcome Pathways Mechanistically Describing Hepatotoxicity.

Callewaert E, Louisse J, Kramer N, Sanz-Serrano J, Vinken M Methods Mol Biol. 2024; 2834:249-273.

PMID: 39312169 DOI: 10.1007/978-1-0716-4003-6_12.


Associations between Ethylene Oxide Exposure and Liver Function in the US Adult Population.

Li S, Wang J, Lei D, Peng D, Zong K, Li K Toxics. 2024; 12(8).

PMID: 39195653 PMC: 11358929. DOI: 10.3390/toxics12080551.


E-waste: mechanisms of toxicity and safety testing.

Eze C, Vinken M FEBS Open Bio. 2024; 14(9):1420-1440.

PMID: 38987214 PMC: 11492355. DOI: 10.1002/2211-5463.13863.


Specific effects on the thyroid relevant for performing a dietary cumulative risk assessment of pesticide residues: 2024 update.

Crivellente F, Hernandez-Jerez A, Lanzoni A, Metruccio F, Mohimont L, Nikolopoulou D EFSA J. 2024; 22(3):e8672.

PMID: 38500786 PMC: 10945593. DOI: 10.2903/j.efsa.2024.8672.


References
1.
Meek M, Boobis A, Crofton K, Heinemeyer G, Raaij M, Vickers C . Risk assessment of combined exposure to multiple chemicals: A WHO/IPCS framework. Regul Toxicol Pharmacol. 2011; . DOI: 10.1016/j.yrtph.2011.03.010. View

2.
Ankley G, Bennett R, Erickson R, Hoff D, Hornung M, Johnson R . Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 2010; 29(3):730-41. DOI: 10.1002/etc.34. View

3.
Carmichael N, Bausen M, Boobis A, Cohen S, Embry M, Fruijtier-Polloth C . Using mode of action information to improve regulatory decision-making: an ECETOC/ILSI RF/HESI workshop overview. Crit Rev Toxicol. 2011; 41(3):175-86. DOI: 10.3109/10408444.2010.541225. View

4.
Cohen S, Arnold L, Eldan M, Lewis A, Beck B . Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit Rev Toxicol. 2006; 36(2):99-133. DOI: 10.1080/10408440500534230. View

5.
Boobis A, Doe J, Heinrich-Hirsch B, Meek M, Munn S, Ruchirawat M . IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit Rev Toxicol. 2008; 38(2):87-96. DOI: 10.1080/10408440701749421. View